White Blood Cell Disorders

50 slides
3.98 MB

Similar Presentations

Presentation Transcript


Author(s): John Levine, M.D., 2009 License:Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution 3.0 License: http://creativecommons.org/licenses/by/3.0/ We have reviewed this material in accordance with U.S. Copyright Law and have tried to maximize your ability to use, share, and adapt it. The citation key on the following slide provides information about how you may share and adapt this material. Copyright holders of content included in this material should contact open.michigan@umich.edu with any questions, corrections, or clarification regarding the use of content. For more information about how to cite these materials visit http://open.umich.edu/education/about/terms-of-use. Any medical information in this material is intended to inform and educate and is not a tool for self-diagnosis or a replacement for medical evaluation, advice, diagnosis or treatment by a healthcare professional. Please speak to your physician if you have questions about your medical condition. Viewer discretion is advised: Some medical content is graphic and may not be suitable for all viewers.


Citation Key for more information see: http://open.umich.edu/wiki/CitationPolicy Use + Share + Adapt Make Your Own Assessment Creative Commons – Attribution License Creative Commons – Attribution Share Alike LicenseCreative Commons – Attribution Noncommercial LicenseCreative Commons – Attribution Noncommercial Share Alike LicenseGNU – Free Documentation LicenseCreative Commons – Zero WaiverPublic Domain – Ineligible: Works that are ineligible for copyright protection in the U.S. (17 USC § 102(b)) *laws in your jurisdiction may differPublic Domain – Expired: Works that are no longer protected due to an expired copyright term.Public Domain – Government: Works that are produced by the U.S. Government. (17 USC § 105)Public Domain – Self Dedicated: Works that a copyright holder has dedicated to the public domain.Fair Use: Use of works that is determined to be Fair consistent with the U.S. Copyright Act. (17 USC § 107) *laws in your jurisdiction may differ Our determination DOES NOT mean that all uses of this 3rd-party content are Fair Uses and we DO NOT guarantee that your use of the content is Fair. To use this content you should do your own independent analysis to determine whether or not your use will be Fair. { Content the copyright holder, author, or law permits you to use, share and adapt. }{ Content Open.Michigan believes can be used, shared, and adapted because it is ineligible for copyright. }{ Content Open.Michigan has used under a Fair Use determination. }


Myeloid Cell DisordersM2 Hematology/Oncology Sequence John Levine, MDWinter 2009


Myeloid Cell Disorders: Goals Define members of the myeloid series Understand: white blood cell maturation the white blood cell count and differential ‘philias’ and ‘penias’ of the myeloid series members and associated clinical settings recruitment of WBC from the circulation. Associate white blood cell defects with function*


Maturation of Myeloid CellsGM-CSFG-CSF*


Mature Myeloid CellsNeutrophilEosinophilBasophilMonocyte*


Assessment of Circulating WBCThe total white blood cell count (WBC) and differential are measured in an automated counter WBC reflects the circulating pool of myeloid and lymphoid cells WBC in each microliter (ml;mm3) is reported Relative proportion of each type of WBC is indicated by a percentage Absolute number is the percentage of each type of WBC multiplied by the total WBC*


White Blood Cell Counts: Normal Ranges*J. Levine


White Blood Cell Counts: Disease States*J. Levine


Neutrophil Maturation25%65%8%2%ProliferationMaturationIntravascular6-7 days6-7 days12 hTissues 12hBone Marrow*J. Levine


Neutrophil Maturation - Proliferative PhaseMyeloblastPromyelocyteMyelocyte25 %Proliferation*Source Undetermined (All Slides)J. Levine


65 % of myeloid cellsMaturation 6-7 daysNeutrophil - Maturation PhaseMetamyelocyteBandNeutrophil*J. LevineSource Undetermined (All Slides)


8%2%12 hTissues 12hIntravascularApproximately 10% of the developing neutrophils are in the circulation, marginated or in the tissue. CirculatingMarginatingFate of the mature neutrophil*


Disorders of Neutrophil Numbers*J. Levine


Definition of Neutrophilia - too manyNormal ANC is 1500-7700/ml Neutrophilia: abnormally high ANC Shift to the left: ↑’d release of precursors from the bone marrow not necessarily associated with neutrophilia*


NeutrophiliaChronic Stimulation Excess cytokine stimulates proliferative pool Causes: Infection Down's Syndrome Pregnancy/Eclampsia Chemotherapy recovery Myeloproliferative disorders Marrow metastases Acute shift from marginating to circulating pool ↑ measured WBC, not total WBC Causes: Steroid treatment Exercise Epinephrine Hypoxia Seizures Other stress*


Example: exercise induced neutrophilia*Source Undetermined


Neutropenia: too fewNeutropenia Definition: ANC < 1500/µl ANC 500-1000 increased risk of infection from exposure ANC < 500: increased risk of infection from host organisms African-Americans: lower normal neutrophil counts (1000-1200)*


Acquired Causes of Neutropenia*


Increased DestructionAnti-neutrophil antibodyNeutrophil-Antibody ComplexUptake and destruction of neutrophil by the RE system*J. Levine


Shift to Marginating PoolCirculatingMarginatingCirculatingMarginatingSevere infection / Endotoxin release Hemodialysis Cardiopulmonary bypass*J. Levine


Evaluation of NeutropeniaIf visit prompted by a fever and ANC is low, treat promptly for infection Suspect medication: major cause of neutropenia If no culprits, bone marrow exam for: Malignancy Infiltration by non-marrow cells Arrest of cell growth Myeloproliferative disorder*


Cyclic Neutropenia21 day cycle autosomal dominant fever, mouth ulcers Treatment G-CSF usually improves after puberty *Source Undetermined


Congenital NeutropeniaMaturation arrest frequent infections, often serious mouth sores may lose teeth or develop severe gum infections Increased risk of leukemia Tx: G-CSF, BMT*Source Undetermined


Role of NeutrophilResponds to chemotactic factors released from damaged tissue Rolls and attaches to the endothelial cell wall protein and carbohydrate interactions (selectins and their ligands). Becomes activated by chemotactic factors Tightly adheres through the integrin family of proteins. Migrates across the endothelial cell wall. Phagocytizes organisms so that they are contained within a vesicle or phagosome. Releases granule products and reduced oxygen species (e.g. hydrogen peroxide and superoxide) to kill organisms*


Function of the Circulating NeutrophilAttachment/rollingActivationAdhesionMigrationPhagocytosis*J. Levine

Browse More Presentations

Last Updated: 8th March 2018

Recommended PPTs